The biopharmaceutical innovation system in Germany: OECD case study on structure, performance, innovation barriers and drivers
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Stuttgart
Fraunhofer-IRB-Verl.
2004
|
| Series: | ISI-Schriftenreihe Innovationspotenziale
|
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Item Description: | Literaturverz. S. 87 - 90 |
| Physical Description: | VI, 90 S. graph. Darst. |
| ISBN: | 3816766463 |
Staff View
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV019795501 | ||
| 003 | DE-604 | ||
| 005 | 20050701 | ||
| 007 | t | ||
| 008 | 050502s2004 gw d||| |||| 00||| eng d | ||
| 015 | |a 05,A15,0509 |2 dnb | ||
| 016 | 7 | |a 973083662 |2 DE-101 | |
| 020 | |a 3816766463 |c kart. : EUR 14.80 |9 3-8167-6646-3 | ||
| 035 | |a (OCoLC)76605360 | ||
| 035 | |a (DE-599)BVBBV019795501 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE | ||
| 049 | |a DE-12 | ||
| 084 | |a 330 |2 sdnb | ||
| 100 | 1 | |a Reiss, Thomas |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a The biopharmaceutical innovation system in Germany |b OECD case study on structure, performance, innovation barriers and drivers |c Thomas Reiss ; Sybille Hinze |
| 264 | 1 | |a Stuttgart |b Fraunhofer-IRB-Verl. |c 2004 | |
| 300 | |a VI, 90 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a ISI-Schriftenreihe Innovationspotenziale | |
| 500 | |a Literaturverz. S. 87 - 90 | ||
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Forschung und Entwicklung |0 (DE-588)4017897-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Marktentwicklung |0 (DE-588)4123713-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Biopharmazie |0 (DE-588)4006890-0 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Deutschland |0 (DE-588)4011882-4 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Deutschland |0 (DE-588)4011882-4 |D g |
| 689 | 0 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 2 | |a Biopharmazie |0 (DE-588)4006890-0 |D s |
| 689 | 0 | 3 | |a Forschung und Entwicklung |0 (DE-588)4017897-3 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Deutschland |0 (DE-588)4011882-4 |D g |
| 689 | 1 | 1 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 1 | 2 | |a Biopharmazie |0 (DE-588)4006890-0 |D s |
| 689 | 1 | 3 | |a Arzneimittelforschung |0 (DE-588)4003120-2 |D s |
| 689 | 1 | 4 | |a Marktentwicklung |0 (DE-588)4123713-4 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Hinze, Sybille |d 1966- |e Verfasser |0 (DE-588)115753966 |4 aut | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013121175&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-013121175 | ||
Record in the Search Index
| _version_ | 1804133286188941312 |
|---|---|
| adam_text | FRAUNHOFER-LNSTITUT FUR SYSTEMTECHNIK UND INNOVATIONSFORSCHUNG ISI
ISI-SCHRIFTENREIHE »LNNOVATIONSPOTENZIALE THOMAS REISS SYBILLE HINZE
THE BIOPHARMACEUTICAL INNOVATION SYSTEM IN GERMANY OECD CASE STUDY ON
STRUTTURE, PERFORMANCE, INNOVATION BARRIERS AND DRIVERS FRAUNHOFER IRB
VERLAG LIST OF CONTENTS LIST OF CONTENTS SEITE 1 INTRODUCTION 1 1.1
GOALS 1 1.2 APPROACH 3 1.3 COUNTRY CHARACTERISTICS 4 1.3.1 GENERAL
INFORMATION 4 1.3.2 MAIN INCLUSTRIES 5 1.3.3 THE PHARMACEUTICAL INDUSTRY
6 2 OVERVIEW OF NATIONAL R&D, TECHNOLOGY AND INNOVATION POLICIES 13 2.1
MAIN ACTORS INVOLVED IN POLICY-MAKING AND POLICY PROGRAMME MANAGEMENT 13
2.2 MAIN VERTICAL POLICIES AND MOST IMPORTARTI HORIZONTAL PROGRAMMES AND
INSTRUMENTS 16 2.2.1 POLICIES FOR KNOWLEDGE BASE SUPPORT 16 2.2.2
POLICIES FOR COMMERCIALISATION SUPPORT 20 2.2.3 POLICIES WITH A
SOCIO-ECONOMIE AND/OR ETHICAL DIMENSION 24 3 STRUCTURE, DYNAMICS AND
PERFORMANCE OF THE BIOPHARMA/BIOMEDICAL SYSTEM 27 3.1 NATIONAL PUBLIC
R&D SYSTEM 27 3.2 BUSINESS SYSTEM 30 3.2.1 BUSINESS ENTRY AND EXIT 30
3.2.2 R&D COOPERATIONS 32 3.2.3 INTERNATIONAL DIMENSION OF THE SYSTEM 36
3.3 PERFORMANCE 37 LIST OF CONTENTS SEITE 4 INNOVATION BARRIERS/DRIVERS
- FRAMEWORK CONDITIONS 45 4.1 KNOWLEDGE SOURCES 45 4.2 HUMAN RESOURCES
47 4.3 FINANCING 50 4.4 REGULATIONS 54 4.5 ENTREPRENEURSHIP 57 5 MARKETS
59 5.1 GENERAL MARKET TRENDS 59 5.2 ORGANISATION OF THE GERMAN HEALTH
CARE SYSTEM 62 5.3 REGULATION OF MARKET ACCESS 65 5.4 ROLEOF USERS 72
5.5 LEAD MARKET FEATURES 73 6 SYNTHESIS AND CONCLUSIONS 77 6.1 SYSTEMIC
IMPERFECTIONS 77 6.2 SYSTEM OPENNESS 81 6.3 ROLEOFDEMAND 82 6.4 POLICY
IMPLICATIONS 82 7 LITERATURE 87
|
| any_adam_object | 1 |
| author | Reiss, Thomas Hinze, Sybille 1966- |
| author_GND | (DE-588)115753966 |
| author_facet | Reiss, Thomas Hinze, Sybille 1966- |
| author_role | aut aut |
| author_sort | Reiss, Thomas |
| author_variant | t r tr s h sh |
| building | Verbundindex |
| bvnumber | BV019795501 |
| ctrlnum | (OCoLC)76605360 (DE-599)BVBBV019795501 |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02344nam a2200553 c 4500</leader><controlfield tag="001">BV019795501</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20050701 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">050502s2004 gw d||| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">05,A15,0509</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">973083662</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3816766463</subfield><subfield code="c">kart. : EUR 14.80</subfield><subfield code="9">3-8167-6646-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)76605360</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019795501</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">330</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Reiss, Thomas</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The biopharmaceutical innovation system in Germany</subfield><subfield code="b">OECD case study on structure, performance, innovation barriers and drivers</subfield><subfield code="c">Thomas Reiss ; Sybille Hinze</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Stuttgart</subfield><subfield code="b">Fraunhofer-IRB-Verl.</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VI, 90 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">ISI-Schriftenreihe Innovationspotenziale</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturverz. S. 87 - 90</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschung und Entwicklung</subfield><subfield code="0">(DE-588)4017897-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Marktentwicklung</subfield><subfield code="0">(DE-588)4123713-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biopharmazie</subfield><subfield code="0">(DE-588)4006890-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Biopharmazie</subfield><subfield code="0">(DE-588)4006890-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Forschung und Entwicklung</subfield><subfield code="0">(DE-588)4017897-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Deutschland</subfield><subfield code="0">(DE-588)4011882-4</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Biopharmazie</subfield><subfield code="0">(DE-588)4006890-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Arzneimittelforschung</subfield><subfield code="0">(DE-588)4003120-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="4"><subfield code="a">Marktentwicklung</subfield><subfield code="0">(DE-588)4123713-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hinze, Sybille</subfield><subfield code="d">1966-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)115753966</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013121175&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-013121175</subfield></datafield></record></collection> |
| geographic | Deutschland (DE-588)4011882-4 gnd |
| geographic_facet | Deutschland |
| id | DE-604.BV019795501 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T20:06:18Z |
| institution | BVB |
| isbn | 3816766463 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-013121175 |
| oclc_num | 76605360 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | VI, 90 S. graph. Darst. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Fraunhofer-IRB-Verl. |
| record_format | marc |
| series2 | ISI-Schriftenreihe Innovationspotenziale |
| spelling | Reiss, Thomas Verfasser aut The biopharmaceutical innovation system in Germany OECD case study on structure, performance, innovation barriers and drivers Thomas Reiss ; Sybille Hinze Stuttgart Fraunhofer-IRB-Verl. 2004 VI, 90 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier ISI-Schriftenreihe Innovationspotenziale Literaturverz. S. 87 - 90 Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Forschung und Entwicklung (DE-588)4017897-3 gnd rswk-swf Arzneimittelforschung (DE-588)4003120-2 gnd rswk-swf Marktentwicklung (DE-588)4123713-4 gnd rswk-swf Biopharmazie (DE-588)4006890-0 gnd rswk-swf Deutschland (DE-588)4011882-4 gnd rswk-swf Deutschland (DE-588)4011882-4 g Pharmazeutische Industrie (DE-588)4045696-1 s Biopharmazie (DE-588)4006890-0 s Forschung und Entwicklung (DE-588)4017897-3 s DE-604 Arzneimittelforschung (DE-588)4003120-2 s Marktentwicklung (DE-588)4123713-4 s Hinze, Sybille 1966- Verfasser (DE-588)115753966 aut GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013121175&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Reiss, Thomas Hinze, Sybille 1966- The biopharmaceutical innovation system in Germany OECD case study on structure, performance, innovation barriers and drivers Pharmazeutische Industrie (DE-588)4045696-1 gnd Forschung und Entwicklung (DE-588)4017897-3 gnd Arzneimittelforschung (DE-588)4003120-2 gnd Marktentwicklung (DE-588)4123713-4 gnd Biopharmazie (DE-588)4006890-0 gnd |
| subject_GND | (DE-588)4045696-1 (DE-588)4017897-3 (DE-588)4003120-2 (DE-588)4123713-4 (DE-588)4006890-0 (DE-588)4011882-4 |
| title | The biopharmaceutical innovation system in Germany OECD case study on structure, performance, innovation barriers and drivers |
| title_auth | The biopharmaceutical innovation system in Germany OECD case study on structure, performance, innovation barriers and drivers |
| title_exact_search | The biopharmaceutical innovation system in Germany OECD case study on structure, performance, innovation barriers and drivers |
| title_full | The biopharmaceutical innovation system in Germany OECD case study on structure, performance, innovation barriers and drivers Thomas Reiss ; Sybille Hinze |
| title_fullStr | The biopharmaceutical innovation system in Germany OECD case study on structure, performance, innovation barriers and drivers Thomas Reiss ; Sybille Hinze |
| title_full_unstemmed | The biopharmaceutical innovation system in Germany OECD case study on structure, performance, innovation barriers and drivers Thomas Reiss ; Sybille Hinze |
| title_short | The biopharmaceutical innovation system in Germany |
| title_sort | the biopharmaceutical innovation system in germany oecd case study on structure performance innovation barriers and drivers |
| title_sub | OECD case study on structure, performance, innovation barriers and drivers |
| topic | Pharmazeutische Industrie (DE-588)4045696-1 gnd Forschung und Entwicklung (DE-588)4017897-3 gnd Arzneimittelforschung (DE-588)4003120-2 gnd Marktentwicklung (DE-588)4123713-4 gnd Biopharmazie (DE-588)4006890-0 gnd |
| topic_facet | Pharmazeutische Industrie Forschung und Entwicklung Arzneimittelforschung Marktentwicklung Biopharmazie Deutschland |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=013121175&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT reissthomas thebiopharmaceuticalinnovationsystemingermanyoecdcasestudyonstructureperformanceinnovationbarriersanddrivers AT hinzesybille thebiopharmaceuticalinnovationsystemingermanyoecdcasestudyonstructureperformanceinnovationbarriersanddrivers |